CoChat

The Mesencephalic Locomotor Region: Multiple Cell Types, Multiple Behavioral Roles, and Multiple Implications for Disease

Open access
Ryczko, Dimitri · 2024 · The Neuroscientist

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

Abstract

The mesencephalic locomotor region (MLR) controls locomotion in vertebrates. In humans with Parkinson disease, locomotor deficits are increasingly associated with decreased activity in the MLR. This brainstem region, commonly considered to include the cuneiform and pedunculopontine nuclei, has been explored as a target for deep brain stimulation to improve locomotor function, but the results are variable, from modest to promising. However, the MLR is a heterogeneous structure, and identification of the best cell type to target is only beginning. Here, I review the studies that uncovered the role of genetically defined MLR cell types, and I highlight the cells whose activation improves locomotor function in animal models of Parkinson disease. The promising cell types to activate comprise some glutamatergic neurons in the cuneiform and caudal pedunculopontine nuclei, as well as some cholinergic neurons of the pedunculopontine nucleus. Activation of MLR GABAergic neurons should be avoided, since they stop locomotion or evoke bouts flanked with numerous stops. MLR is also considered a potential target in spinal cord injury, supranuclear palsy, primary progressive freezing of gait, or stroke. Better targeting of the MLR cell types should be achieved through optimized deep brain stimulation protocols, pharmacotherapy, or the development of optogenetics for human use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/10738584221139136

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Brainstem locomotor circuits are evolutionary conserved. (A) Left: vertebrate evolution from lamprey to mammals. Right: the three basic layers of the locomotor circuitry conserved in vertebrates. (B–E) Brains of lamprey (adapted from Ryczko and others 2020), zebrafish (adapted from Carbo-Tano and others 2022), salamander (Ryczko, Auclair, and others 2016), and rodent (adapted from Ryczko, Cone, and others 2016). In mammals, many reticulospinal neurons are distributed in the pontine and medullary reticular formations (RFs). Possible homologs of the mammalian pontine RFs are highlighted in lamprey (anterior rhombencephalic reticular nucleus [ARRN], middle rhombencephalic reticular nucleus [MRRN]), zebrafish (pontine reticular formation, retropontine reticular formation [RetroP]), and salamander (superior reticular nucleus [sRN], middle reticular nucleus [mRN]). Possible homologs of the mammalian medullary RFs are also highlighted in lamprey (posterior rhombencephalic reticular nucleus [PRRN]), zebrafish (medullary reticular formation), and salamander (inferior reticular nucleus [iRN]). Bottom: schematic illustrations of transverse slices at the level of the mesencephalic locomotor region (MLR). Efficient MLR stimulation sites colocalize with cholinergic neurons (positive for choline acetyltransferase [ChAT]) of the pedunculopontine nucleus in mammals, the pedunculopontine nucleus and laterodorsal tegmental nucleus in lamprey and salamander, and a putative homolog ChAT+ cell group in zebrafish. This indicates that MLR neurons generating the locomotor drive are consistently located around the cholinergic population in vertebrates. (F–H) Electrical stimulation of the MLR evokes swimming in a lamprey semi-intact preparation, in which the brain is accessible and the body is free to move (adapted from Brocard and others 2010; Ryczko and others 2020) and in larval zebrafish with the head embedded in agarose and the body free to move (adapted from Carbo-Tano and others 2022). In a salamander semi-intact preparation, low-intensity MLR stimulation evokes walking, and higher stimulation intensities evoke swimming (adapted from Cabelguen and others 2003). In rats and mice, electrical stimulation of the MLR evokes walking movements on ground and swimming movements underwater (adapted from Bachmann and others 2013; see also Roussel and others 2022). CnF, cuneiform nucleus; PPN, pedunculopontine nucleus.
Figure 1. Brainstem locomotor circuits are evolutionary conserved. (A) Left: vertebrate evolution from lamprey to mammals. Right: the three basic layers of the locomotor circuitry conserved in vertebrates. (B–E) Brains of lamprey (adapted from Ryczko and others 2020), zebrafish (adapted from Carbo-Tano and others 2022), salamander (Ryczko, Auclair, and others 2016), and rodent (adapted from Ryczko, Cone, and others 2016). In mammals, many reticulospinal neurons are distributed in the pontine and medullary reticular formations (RFs). Possible homologs of the mammalian pontine RFs are highlighted in lamprey (anterior rhombencephalic reticular nucleus [ARRN], middle rhombencephalic reticular nucleus [MRRN]), zebrafish (pontine reticular formation, retropontine reticular formation [RetroP]), and salamander (superior reticular nucleus [sRN], middle reticular nucleus [mRN]). Possible homologs of the mammalian medullary RFs are also highlighted in lamprey (posterior rhombencephalic reticular nucleus [PRRN]), zebrafish (medullary reticular formation), and salamander (inferior reticular nucleus [iRN]). Bottom: schematic illustrations of transverse slices at the level of the mesencephalic locomotor region (MLR). Efficient MLR stimulation sites colocalize with cholinergic neurons (positive for choline acetyltransferase [ChAT]) of the pedunculopontine nucleus in mammals, the pedunculopontine nucleus and laterodorsal tegmental nucleus in lamprey and salamander, and a putative homolog ChAT+ cell group in zebrafish. This indicates that MLR neurons generating the locomotor drive are consistently located around the cholinergic population in vertebrates. (F–H) Electrical stimulation of the MLR evokes swimming in a lamprey semi-intact preparation, in which the brain is accessible and the body is free to move (adapted from Brocard and others 2010; Ryczko and others 2020) and in larval zebrafish with the head embedded in agarose and the body free to move (adapted from Carbo-Tano and others 2022). In a salamander semi-intact preparation, low-intensity MLR stimulation evokes walking, and higher stimulation intensities evoke swimming (adapted from Cabelguen and others 2003). In rats and mice, electrical stimulation of the MLR evokes walking movements on ground and swimming movements underwater (adapted from Bachmann and others 2013; see also Roussel and others 2022). CnF, cuneiform nucleus; PPN, pedunculopontine nucleus.CC BY · PubMed Central
Figure 2. Effects of mesencephalic locomotor region (MLR) cell type stimulation in intact rodents and in rodent models of Parkinson disease (PD). Left: illustration of a slice of the mouse brain at the level of the MLR. The dorsal part (cuneiform nucleus [CnF]) and the ventral part (pedunculopontine nucleus [PPN]) are delineated. On the right, the locomotor (loco) effects resulting from optogenetic (opto) or chemogenetic (chemo) activation of MLR glutamatergic neurons (positive for vesicular glutamate transporter 2 [Vglut2]), GABAergic neurons (positive for vesicular GABA transporter [VGAT]), or cholinergic neurons (positive for choline acetyltransferase [ChAT]) in intact rodents and in rodent animal models of PD. Note that some authors targeted MLR CamKIIa+ neurons (e.g., Carvalho and others 2020), among which many but not all are glutamatergic (Kreeger and others 2021; Meng and others 2016; Roseberry and others 2016; Wang and others 2013). Also note that the first studies targeted the MLR at large, without precisely targeting the CnF or PPN (Capelli and others 2017; Lee and others 2014; Roseberry and others 2016).
Figure 2. Effects of mesencephalic locomotor region (MLR) cell type stimulation in intact rodents and in rodent models of Parkinson disease (PD). Left: illustration of a slice of the mouse brain at the level of the MLR. The dorsal part (cuneiform nucleus [CnF]) and the ventral part (pedunculopontine nucleus [PPN]) are delineated. On the right, the locomotor (loco) effects resulting from optogenetic (opto) or chemogenetic (chemo) activation of MLR glutamatergic neurons (positive for vesicular glutamate transporter 2 [Vglut2]), GABAergic neurons (positive for vesicular GABA transporter [VGAT]), or cholinergic neurons (positive for choline acetyltransferase [ChAT]) in intact rodents and in rodent animal models of PD. Note that some authors targeted MLR CamKIIa+ neurons (e.g., Carvalho and others 2020), among which many but not all are glutamatergic (Kreeger and others 2021; Meng and others 2016; Roseberry and others 2016; Wang and others 2013). Also note that the first studies targeted the MLR at large, without precisely targeting the CnF or PPN (Capelli and others 2017; Lee and others 2014; Roseberry and others 2016).CC BY · PubMed Central
Figure 3. Optogenetic stimulation of glutamatergic neurons in the cuneiform nucleus controls locomotion in intact mice. (A–C) In an open field, blue light (470 nm) shone with a laser in the cuneiform nucleus (CnF) of mice expressing the ion-sensitive channel channelrhodopsin in glutamatergic neurons (positive for the vesicular glutamatergic transporter 2 [Vglut2]) evoked locomotion. Increasing laser power increased locomotor speed. Each data point is the average of 3 to 5 mice. (B) Data are presented as mean (black) ± SEM (grey). (C) Data are presented as mean ± SEM. Black line, sigmoidal fit; dotted lines, 95% prediction intervals. (D) In a linear corridor, the footfall pattern evoked by optogenetic stimulation of CnF Vglut2+ neurons was similar to that recorded during spontaneous locomotion. Each rectangle represents the normalized duration of the stance phase for each limb. (E, F) In a linear corridor, the hindlimb kinematics evoked by optogenetic stimulation of CnF Vglut2+ neurons were similar to those recorded during spontaneous locomotion. (F) Time elapsed from first to last frame is 700 ms (top) and 500 ms (bottom). (G, H) During tonic optogenetic stimulation of CnF Vglut2+ neurons, multiple slow-downs were smoothly achieved (highlighted with white filled dots). (I) The slow-downs were happening when the mouse was approaching the walls of the arena, indicating that dynamic integration of visual inputs and generation of steering commands by the distinct steering circuitry (Cregg and others 2020; Usseglio and others 2020) are still possible during tonic stimulation of Vglut2+ CnF neurons. Panels A–I adapted from van der Zouwen and others (2021). FL, forelimb; HL, hindlimb; MTP, metatarsophalangeal.
Figure 3. Optogenetic stimulation of glutamatergic neurons in the cuneiform nucleus controls locomotion in intact mice. (A–C) In an open field, blue light (470 nm) shone with a laser in the cuneiform nucleus (CnF) of mice expressing the ion-sensitive channel channelrhodopsin in glutamatergic neurons (positive for the vesicular glutamatergic transporter 2 [Vglut2]) evoked locomotion. Increasing laser power increased locomotor speed. Each data point is the average of 3 to 5 mice. (B) Data are presented as mean (black) ± SEM (grey). (C) Data are presented as mean ± SEM. Black line, sigmoidal fit; dotted lines, 95% prediction intervals. (D) In a linear corridor, the footfall pattern evoked by optogenetic stimulation of CnF Vglut2+ neurons was similar to that recorded during spontaneous locomotion. Each rectangle represents the normalized duration of the stance phase for each limb. (E, F) In a linear corridor, the hindlimb kinematics evoked by optogenetic stimulation of CnF Vglut2+ neurons were similar to those recorded during spontaneous locomotion. (F) Time elapsed from first to last frame is 700 ms (top) and 500 ms (bottom). (G, H) During tonic optogenetic stimulation of CnF Vglut2+ neurons, multiple slow-downs were smoothly achieved (highlighted with white filled dots). (I) The slow-downs were happening when the mouse was approaching the walls of the arena, indicating that dynamic integration of visual inputs and generation of steering commands by the distinct steering circuitry (Cregg and others 2020; Usseglio and others 2020) are still possible during tonic stimulation of Vglut2+ CnF neurons. Panels A–I adapted from van der Zouwen and others (2021). FL, forelimb; HL, hindlimb; MTP, metatarsophalangeal.CC BY · PubMed Central
Figure 4. Functional outputs of (A) the cuneiform nucleus (CnF) and (B) the pedunculopontine nucleus (PPN). Note that only the projections tested functionally with genetic tools on rodents were included here, but more anatomical projections were reported. For instance, the descending cholinergic projections of the PPN are well established (Gut and Mena-Segovia 2019; Mena-Segovia and Bolam 2017; for review, Ryczko and Dubuc 2013). For the sake of simplicity, in the CnF and PPN, all cells with the same transmitter were pooled in a single circle. The interconnectivity among mesencephalic locomotor region cell types and whether the different projection patterns originate from distinct populations of neurons are not fully resolved. The green question mark highlights that it is not known whether this CamKIIa+ projection to BF originates from PPN or CnF, because the distinction was not made in Lee and others (2014). For details about the behavioral role of these projections, see main text. BF, basal forebrain; Cardio, cardiovascular; Entorh, entorhinal; Gi, gigantocellular nucleus; GPe external globus pallidus; HDB, horizontal limb of the diagonal band of Broca; LPGi, lateral paragigantocellular nucleus; Respi, respiratory; RS, reticulospinal; SNc, dopaminergic neurons of the substantia nigra pars compacta; SNr, substantia nigra pars reticulata; STN, subthalamic nucleus; Thalam, thalamus; VTA, dopaminergic neurons of the ventral tegmental area. The brain picture was kindly provided by GENSAT and previously used as a background image in Fougère and others (2019).
Figure 4. Functional outputs of (A) the cuneiform nucleus (CnF) and (B) the pedunculopontine nucleus (PPN). Note that only the projections tested functionally with genetic tools on rodents were included here, but more anatomical projections were reported. For instance, the descending cholinergic projections of the PPN are well established (Gut and Mena-Segovia 2019; Mena-Segovia and Bolam 2017; for review, Ryczko and Dubuc 2013). For the sake of simplicity, in the CnF and PPN, all cells with the same transmitter were pooled in a single circle. The interconnectivity among mesencephalic locomotor region cell types and whether the different projection patterns originate from distinct populations of neurons are not fully resolved. The green question mark highlights that it is not known whether this CamKIIa+ projection to BF originates from PPN or CnF, because the distinction was not made in Lee and others (2014). For details about the behavioral role of these projections, see main text. BF, basal forebrain; Cardio, cardiovascular; Entorh, entorhinal; Gi, gigantocellular nucleus; GPe external globus pallidus; HDB, horizontal limb of the diagonal band of Broca; LPGi, lateral paragigantocellular nucleus; Respi, respiratory; RS, reticulospinal; SNc, dopaminergic neurons of the substantia nigra pars compacta; SNr, substantia nigra pars reticulata; STN, subthalamic nucleus; Thalam, thalamus; VTA, dopaminergic neurons of the ventral tegmental area. The brain picture was kindly provided by GENSAT and previously used as a background image in Fougère and others (2019).CC BY · PubMed Central
Figure 5. Optogenetic stimulation of glutamatergic neurons in the cuneiform nucleus (CnF) controls locomotion in a mouse model of Parkinson disease. (A–D) To model Parkinson disease, a neurotoxin (6-hydroxydopamine [6-OHDA]) was injected in the striatum of mice expressing the ion-sensitive channel channelrhodopsin and the fluorescent protein EYFP in glutamatergic neurons (positive for the vesicular glutamatergic transporter 2 [Vglut2]). In control mice, only a vehicle solution was injected in the striatum. Intrastriatal 6-OHDA destroyed dopaminergic fibers positive for tyrosine hydroxylase in the striatum, but intrastriatal vehicle solution did not. An optic fiber was implanted in the CnF and connected to a laser-generating blue light (470 nm) to activate CnF Vglut2+ neurons. (E, F) In an open field, mouse locomotion was filmed from above during optogenetic stimulation (10 s, blue lines) and in between stimulations (80 s, black lines). Between optogenetic stimulations, spontaneous locomotion was severely lowered in 6-OHDA mice as compared with control mice, in which dopaminergic neurons were not destroyed. (G, H) Optogenetic stimulation of CnF Vglut2+ neurons increased locomotor speed (mean ± SEM) in 6-OHDA mice as in control mice. (I, J) Increasing laser power increased locomotor speed in 6-OHDA mice as in control mice. Data are presented as mean ± SEM. Black line, sigmoidal fit; dotted lines, 95% CI. (K, L) In a linear corridor, hindlimb kinematics were filmed from the side and analyzed with DeepLabCut (see also Figure 3E). The angle excursions (mean ± SD) in the hip, knee, ankle, and metatarsophalangeal (MTP) joints during locomotion evoked by optogenetic stimulation of CnF Vglut2+ neurons were largely similar to those recorded during spontaneous locomotion before the destruction of dopaminergic neurons. In control mice, hindlimb joint angle excursions (mean ± SD) during locomotion evoked by optogenetic stimulation of CnF Vglut2+ neurons were largely similar to those recorded during spontaneous locomotion before the injection of a vehicle solution in the striatum. Panels A–L adapted from Fougère and others (2021). IC, inferior colliculus; PAG, periaqueductal gray.
Figure 5. Optogenetic stimulation of glutamatergic neurons in the cuneiform nucleus (CnF) controls locomotion in a mouse model of Parkinson disease. (A–D) To model Parkinson disease, a neurotoxin (6-hydroxydopamine [6-OHDA]) was injected in the striatum of mice expressing the ion-sensitive channel channelrhodopsin and the fluorescent protein EYFP in glutamatergic neurons (positive for the vesicular glutamatergic transporter 2 [Vglut2]). In control mice, only a vehicle solution was injected in the striatum. Intrastriatal 6-OHDA destroyed dopaminergic fibers positive for tyrosine hydroxylase in the striatum, but intrastriatal vehicle solution did not. An optic fiber was implanted in the CnF and connected to a laser-generating blue light (470 nm) to activate CnF Vglut2+ neurons. (E, F) In an open field, mouse locomotion was filmed from above during optogenetic stimulation (10 s, blue lines) and in between stimulations (80 s, black lines). Between optogenetic stimulations, spontaneous locomotion was severely lowered in 6-OHDA mice as compared with control mice, in which dopaminergic neurons were not destroyed. (G, H) Optogenetic stimulation of CnF Vglut2+ neurons increased locomotor speed (mean ± SEM) in 6-OHDA mice as in control mice. (I, J) Increasing laser power increased locomotor speed in 6-OHDA mice as in control mice. Data are presented as mean ± SEM. Black line, sigmoidal fit; dotted lines, 95% CI. (K, L) In a linear corridor, hindlimb kinematics were filmed from the side and analyzed with DeepLabCut (see also Figure 3E). The angle excursions (mean ± SD) in the hip, knee, ankle, and metatarsophalangeal (MTP) joints during locomotion evoked by optogenetic stimulation of CnF Vglut2+ neurons were largely similar to those recorded during spontaneous locomotion before the destruction of dopaminergic neurons. In control mice, hindlimb joint angle excursions (mean ± SD) during locomotion evoked by optogenetic stimulation of CnF Vglut2+ neurons were largely similar to those recorded during spontaneous locomotion before the injection of a vehicle solution in the striatum. Panels A–L adapted from Fougère and others (2021). IC, inferior colliculus; PAG, periaqueductal gray.CC BY · PubMed Central
Figure 6. Chemogenetic activation of glutamatergic (Vglut2+) or GABAergic (VGAT+) neurons in the caudal pedunculopontine nucleus has different effects on locomotion in mouse models of Parkinson disease (PD). (A) To model the akinesia seen in PD, Masini and Kiehn (2022) injected intraperitoneally in mice a D2 antagonist (haloperidol) or a D1 antagonist (SCH 23390). (B) Calcium activity of striatal neurons were measured with a miniaturized microscope coupled with a GRIN lens positioned above the dorsal striatum (STR) of D1-cre mice injected in the STR with an adeno-associated virus expressing the genetically encoded calcium sensor GCaMP6s in a cre-dependent manner. (C) Top left: field of view showing neurons expressing GCaMP6s in white (scale 100 μm). Top right: coronal section illustrating lens position above the dorsal STR (scale 1 mm), with GCamP6s in magenta and neurotrace in black. The lower panel presents a typical example of calcium activity (Z score) from four cells in the field of view after intraperitoneal application of a D2 antagonist (haloperidol). (D) Distance moved in the open field before and after the dopaminergic antagonist injection. Individuals are represented by thin lines; group mean ± SEM are in black. (E, I) Viral strategies to bilaterally express excitatory DREADD in caudal pedunculopontine nucleus (PPN) Vglut2+ neurons or caudal PPN VGAT+ neurons. (F, J) Top: representative trajectory of the animal in the open field (scale, 25 cm) after DREADD activation. Bottom: instantaneous speed of the animal following DREADD activation in PPN Vglut2+ or VGAT+ neurons. Stop events in absence of in-place behavior are illustrated by red dots. (G, H, K, L) Timeline effect of D1 or D2 antagonist before (light gray background) and after (gray) DREADD activation in sham. Vglut2-cre mice injected in the caudal PPN with DREADD (green) and VGAT-cre mice injected in the caudal PPN with DREADD (blue). Two-way repeated measures analysis of variance with graph reporting group effect and analysis done for each period (i.e., before and after DREADD activation). Data are presented as mean ± SEM. ns, not significant. *P < 0.05. **P < 0.01. ***P < 0.001. (M, N) Hindlimb kinematics were filmed from the side, and the angular excursions in the knee and ankle joints were analyzed with DeepLabCut. (O) Angular excursions (mean ± 95% CI) of knee and ankle joints during a complete locomotor cycle. Panel A adapted from van der Zouwen and others (2021). Panel B adapted from Fougère and others (2021). Panels C–O adapted from Masini and Kiehn (2022). CNO, clozapine N-oxide; DREADD, designer receptors exclusively activated by designer drugs.
Figure 6. Chemogenetic activation of glutamatergic (Vglut2+) or GABAergic (VGAT+) neurons in the caudal pedunculopontine nucleus has different effects on locomotion in mouse models of Parkinson disease (PD). (A) To model the akinesia seen in PD, Masini and Kiehn (2022) injected intraperitoneally in mice a D2 antagonist (haloperidol) or a D1 antagonist (SCH 23390). (B) Calcium activity of striatal neurons were measured with a miniaturized microscope coupled with a GRIN lens positioned above the dorsal striatum (STR) of D1-cre mice injected in the STR with an adeno-associated virus expressing the genetically encoded calcium sensor GCaMP6s in a cre-dependent manner. (C) Top left: field of view showing neurons expressing GCaMP6s in white (scale 100 μm). Top right: coronal section illustrating lens position above the dorsal STR (scale 1 mm), with GCamP6s in magenta and neurotrace in black. The lower panel presents a typical example of calcium activity (Z score) from four cells in the field of view after intraperitoneal application of a D2 antagonist (haloperidol). (D) Distance moved in the open field before and after the dopaminergic antagonist injection. Individuals are represented by thin lines; group mean ± SEM are in black. (E, I) Viral strategies to bilaterally express excitatory DREADD in caudal pedunculopontine nucleus (PPN) Vglut2+ neurons or caudal PPN VGAT+ neurons. (F, J) Top: representative trajectory of the animal in the open field (scale, 25 cm) after DREADD activation. Bottom: instantaneous speed of the animal following DREADD activation in PPN Vglut2+ or VGAT+ neurons. Stop events in absence of in-place behavior are illustrated by red dots. (G, H, K, L) Timeline effect of D1 or D2 antagonist before (light gray background) and after (gray) DREADD activation in sham. Vglut2-cre mice injected in the caudal PPN with DREADD (green) and VGAT-cre mice injected in the caudal PPN with DREADD (blue). Two-way repeated measures analysis of variance with graph reporting group effect and analysis done for each period (i.e., before and after DREADD activation). Data are presented as mean ± SEM. ns, not significant. *P < 0.05. **P < 0.01. ***P < 0.001. (M, N) Hindlimb kinematics were filmed from the side, and the angular excursions in the knee and ankle joints were analyzed with DeepLabCut. (O) Angular excursions (mean ± 95% CI) of knee and ankle joints during a complete locomotor cycle. Panel A adapted from van der Zouwen and others (2021). Panel B adapted from Fougère and others (2021). Panels C–O adapted from Masini and Kiehn (2022). CNO, clozapine N-oxide; DREADD, designer receptors exclusively activated by designer drugs.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 126 references

Research works printed but not linked: 4

  1. Fougère M, 2019, Curr Opin Physiol, 8
  2. Leimbach F, 2019, Clin Park Relat Disord, 1, 48
  3. Ratner M, 2021, Nat Biotechnol, 39
  4. Shik ML, 1966, Biofizika, 11

Cited by

See all 31

Metadata

Authors
Ryczko, D.
Affiliations
Université de Sherbrooke (CA)
Corresponding author
Ryczko, Dimitri
Venue
The Neuroscientist
Published
2022-12-28
Volume
30
Issue
3
Pages
347-366
ISSN
  • 1073-8584 (ISSN-L)
  • 1089-4098
OpenAlex
W4312215232
Cited by
31
References
124
Citations by year
2026: 6 · 2025: 13 · 2024: 7 · 2023: 5
FWCI
0.90
Type
journal article
Language
en
Open access
Locations
  • The Neuroscientist (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Faculté de médecine et des sciences de la santé
  • Fonds Jean-Luc Mongrain de la fondation du CHUS
  • H2020 European Research Council (951477)
  • Canada Foundation for Innovation (39344)
  • Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-05522, RTI-2019-00628)
  • Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke
  • Canadian Institutes of Health Research (407083)
  • Centre d’excellence en Neurosciences de l’Université de Sherbrooke
  • Fonds de la Recherche du Québec - Santé (297238, 34920, 36772)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
mesencephalic locomotor region, Parkinson's disease, locomotion, deep brain stimulation, cuneiform nucleus, pedunculopontine nucleus, glutamatergic neurons, cholinergic neurons, GABAergic neurons, cellular heterogeneity, freezing of gait, spinal cord injury, progressive supranuclear palsy, stroke, optogenetics
MeSH terms
Animals, Humans, Locomotion, Mesencephalon, Neurons, Parkinson Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Mesencephalic Locomotor Region: Multiple Cell Types, Multiple Behavioral Roles, and Multiple Implications for Disease. https://app.cochat.ai/papers/10.1177/10738584221139136
The paper
Ryczko, D. (2024). The Mesencephalic Locomotor Region: Multiple Cell Types, Multiple Behavioral Roles, and Multiple Implications for Disease. The Neuroscientist. https://doi.org/10.1177/10738584221139136

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.